Cargando…
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2
BACKGROUND: MicroRNA (miRNA) dysregulation was commonly seen in papillary thyroid carcinoma (PTC), and miR-195 was verified to be downregulated in PTC by the large data set analysis from The Cancer Genome Atlas (TCGA). Our study aimed to explore the biological functions and the underlying molecular...
Autores principales: | Yin, Yali, Hong, Shubin, Yu, Shuang, Huang, Yanrui, Chen, Shuwei, Liu, Yujie, Zhang, Quan, Li, Yanbing, Xiao, Haipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504932/ https://www.ncbi.nlm.nih.gov/pubmed/28740507 http://dx.doi.org/10.1155/2017/6180425 |
Ejemplares similares
-
TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
por: Yu, Shuang, et al.
Publicado: (2020) -
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1
por: Han, Kang, et al.
Publicado: (2015) -
STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
por: He, Weiman, et al.
Publicado: (2023) -
MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
por: Wang, Jing, et al.
Publicado: (2020) -
Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
por: Hong, Shubin, et al.
Publicado: (2023)